BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Munesue SI, Liang M, Harashima A, Zhong J, Furuhara K, Boitsova EB, Cherepanov SM, Gerasimenko M, Yuhi T, Yamamoto Y, Higashida H. Transport of oxytocin to the brain after peripheral administration by membrane-bound or soluble forms of receptors for advanced glycation end-products. J Neuroendocrinol 2021;33:e12963. [PMID: 33733541 DOI: 10.1111/jne.12963] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Yeomans DC, Hanson LR, Carson DS, Tunstall BJ, Lee MR, Tzabazis AZ, Jacobs D, Frey WH 2nd. Nasal oxytocin for the treatment of psychiatric disorders and pain: achieving meaningful brain concentrations. Transl Psychiatry 2021;11:388. [PMID: 34247185 DOI: 10.1038/s41398-021-01511-7] [Reference Citation Analysis]
2 Liu N, Yang H, Han L, Ma M. Oxytocin in Women's Health and Disease. Front Endocrinol (Lausanne) 2022;13:786271. [PMID: 35242106 DOI: 10.3389/fendo.2022.786271] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Higashida H, Gerasimenko M, Yamamoto Y. Receptor for advanced glycation end-products and child neglect in mice: A possible link to postpartum depression. Comprehensive Psychoneuroendocrinology 2022. [DOI: 10.1016/j.cpnec.2022.100146] [Reference Citation Analysis]
4 Al-Suhaimi EA, Nawaz M, Khan FA, Aljafary MA, Baykal A, Homeida AM. Emerging trends in the delivery of nanoformulated oxytocin across Blood-Brain barrier. Int J Pharm 2021;609:121141. [PMID: 34597727 DOI: 10.1016/j.ijpharm.2021.121141] [Reference Citation Analysis]